In this two-part Expert video series, Dr. Roy Chemaly answers Frequently Asked Questions (FAQs) about diagnosing latent TB infection (LTBI) in immunocompromised patient populations.
Video 1: Answers to FAQs: LTBI Testing Methodologies (run time: 9m, 52s)
Video 2: Answers to FAQs: Immunocompromised Patient Populations (run time: 10m, 18s)
Dr. Chemaly is a Professor of Medicine in the Department of Infectious Diseases, Infection Control & Employee Health at The University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Chemaly is the Director of the Infection Control and the Antimicrobial Stewardship programs at MD Anderson Cancer Center. He heads the Viral Protection Ad Hoc Infection Control Subcommittee, and serves as Director of the Clinical Virology Research Program in the Department of Infectious Diseases.